Appropriateness of β-thalassemia trait screening in patients with hypochromic microcytic anemia and predictors of potentially low-yield testing.
Blood test patterns can identify which anemia patients truly need β-thalassemia screening, reducing unnecessary testing.
This study evaluated the appropriateness of β-thalassemia trait testing in patients presenting with hypochromic microcytic anemia and identified CBC-derived predictors of low-yield hemoglobin electrophoresis. The findings provide a practical framework to risk-stratify patients and reduce unnecessary β-thalassemia screening tests while maintaining sensitivity for true trait carriers.
What the study was
- Study design
- cohort_study
- Category
- hematological diagnostics
- Maturity
- Validated
- Journal
- Scientific Reports
Why it surfaced
Sentinel-detected article addressing CBC-based diagnostic decision optimization for β-thalassemia trait screening. Fills a practical clinical gap in CBC parameter-guided testing decisions, adjacent to the CBC diagnostics watchlist topic (T2).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.